Rumalon in knee osteoarthritis: blinded first year and two-year extension
Randomized study in people · 1987
- What was studied
- 50 people with knee osteoarthritis at Hospital General, Mexico City. Twenty-five were randomized to each group in year one.
- Main finding
- The first, double-blind year found no significant advantage over placebo in 50 randomized patients. Both groups received Rumalon in the two-year extension.
Reported findings and study design
One year of parallel, double-blind, randomized treatment versus placebo, followed by two open years of active treatment in both groups.
Population or model 50 people with knee osteoarthritis at Hospital General, Mexico City. Twenty-five were randomized to each group in year one.
Dose, route and schedule
Rumalon 2 mL intramuscularly three times a week during eight-week courses. Three courses in year one. Both groups received active treatment in years two and three, two courses per year.
Protocol source ↗ · Original indexed abstract and opening page of the journal article scan.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| End of the blinded comparison | No statistically significant between-group differences | Year 1 · 25 randomized per arm |
| Night and rest pain | Reported improvement favored two years of active exposure over one year | Year 2 |
| Radiographic severity | 16% improved, 74% unchanged, 10% worsened | Year 3, after both groups received active drug |
| Symptoms in the extension | Rest and walking pain and morning stiffness improved overall. Night pain and pain while standing or climbing stairs showed no significant overall improvement. | Year 3 |
Year-three imaging was assessed blind. The extension had no concurrent placebo group.
Source for these results ↗ · Reviewed 2026-11-15
Study limitations and source details
Study limitations
- Anti-inflammatory drugs and physiotherapy were allowed. Comparisons after year one reflect groups with different durations of active treatment. The accessible abstract gives no adverse-event counts.
Source details
Original indexed abstract and opening page of the journal article scan.
Sources checked
Citation
G. Katona. Rumalon in knee osteoarthritis: blinded first year and two-year extension Current Medical Research and Opinion. 1987;10(9):625–633.
Study source ↗ · DOI 10.1185/03007998709112416 · Bibliography entry · Link to this summary